Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126006001 | 12600600 | 1 | I | 201604 | 20160713 | 20160727 | 20160727 | EXP | CA-AMGEN-CANSP2016061262 | CA-HQ SPECIALTY-CA-2016INT000624 | INTERCHEM | 71.00 | YR | F | Y | 0.00000 | 20160727 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126006001 | 12600600 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | 201749 | |||||||||||
| 126006001 | 12600600 | 2 | SS | ENBREL | ETANERCEPT | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 4 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 5 | SS | ORENCIA | ABATACEPT | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 6 | SS | SIMPONI | GOLIMUMAB | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 7 | SS | GOLD | GOLD | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 8 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 9 | SS | ARAVA | LEFLUNOMIDE | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 10 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 11 | SS | REMICADE | INFLIXIMAB | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 12 | SS | RITUXAN | RITUXIMAB | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 13 | SS | HUMIRA | ADALIMUMAB | 1 | UNK | 0 | |||||||||||
| 126006001 | 12600600 | 14 | SS | LYRICA | PREGABALIN | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126006001 | 12600600 | 1 | Rheumatoid arthritis |
| 126006001 | 12600600 | 2 | Rheumatoid arthritis |
| 126006001 | 12600600 | 3 | Rheumatoid arthritis |
| 126006001 | 12600600 | 4 | Product used for unknown indication |
| 126006001 | 12600600 | 5 | Product used for unknown indication |
| 126006001 | 12600600 | 6 | Product used for unknown indication |
| 126006001 | 12600600 | 7 | Product used for unknown indication |
| 126006001 | 12600600 | 8 | Product used for unknown indication |
| 126006001 | 12600600 | 9 | Product used for unknown indication |
| 126006001 | 12600600 | 10 | Product used for unknown indication |
| 126006001 | 12600600 | 11 | Product used for unknown indication |
| 126006001 | 12600600 | 12 | Product used for unknown indication |
| 126006001 | 12600600 | 13 | Product used for unknown indication |
| 126006001 | 12600600 | 14 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126006001 | 12600600 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126006001 | 12600600 | Condition aggravated | |
| 126006001 | 12600600 | Drug intolerance | |
| 126006001 | 12600600 | Sinusitis | |
| 126006001 | 12600600 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |